Piper Companies is seeking a remote Biostatistician for a pharmaceutical services leader. The Biostatistician will be responsible designing and analyzing clinical trials, collaborating with cross-functional teams to support drug development and regulatory submissions, and applying advanced statistical methods to ensure high-quality, data-driven decision-making in a fast-paced biotech environment. This role is remote and prefers the candidate to sit on the east coast.

Responsibilities of the Biostatistician:

• Design and analyze clinical trials and contribute to the clinical development plan of a compound/program.
• Collaborate with cross-functional teams and stakeholders to deliver statistical components for clinical trials and regulatory submissions.
• Ensure statistical processes align with company guidelines and regulatory standards.
• Lead and monitor statistical activities across multiple clinical trials.
• Communicate complex statistical concepts clearly to both technical and non-technical audiences.

Qualifications for the Biostatistician:

• 5+ years of relevant experience.
• Strong expertise in biostatistics and its application in drug development and clinical trials.
• Proficiency in statistical software such as SAS and/or R.
• Experience with regulatory submissions and knowledge of eCRT and Define standards.
• Demonstrated leadership in managing cross-functional teams and statistical deliverables.
• Preferably experienced in Immunology and familiar with modern statistical models and design approaches.
• Masters or PhD. in Statistics or related field.

• Design and analyze clinical trials and contribute to the clinical development plan of a compound/program.
• Collaborate with cross-functional teams and stakeholders to deliver statistical components for clinical trials and regulatory submissions.
• Ensure statistical processes align with company guidelines and regulatory standards.
• Lead and monitor statistical activities across multiple clinical trials.
• Communicate complex statistical concepts clearly to both technical and non-technical audiences